V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280007951 | 280010449 | 1.7 | 79.7 | Palliative (P) | 2016-01-22 | 2016-01-22 | Cetuximab + Radiotherapy Maint | N | Y | 280025889 | CETUXIMAB + RT |
| 280007952 | 280005210 | 1.58 | null | Palliative (P) | 2013-04-22 | 2013-04-25 | Cetuximab + Radiotherapy Maint | N | N | 280025897 | CETUXIMAB + RT |
| 280007953 | 280005211 | 1.7 | 65.5 | Palliative (P) | 2013-07-14 | 2013-08-05 | Ifosfamide | 2 | N | 280025898 | IFOSFAMIDE |
| 280007954 | 280005212 | null | 16 | Adjuvant (A) | 2014-07-05 | 2014-05-28 | CARBOPLATIN + RT | 02 | Y | 280025900 | CARBOPLATIN + RT |
| 280007955 | 280012068 | null | null | Adjuvant (A) | 2018-02-02 | 2018-02-21 | CARBOPLATIN + RT | N | Y | 280025904 | CARBOPLATIN + RT |
| 280007956 | 280005215 | 1.62 | 109.6 | Palliative (P) | 2014-03-31 | 2014-04-17 | Cetuximab + Radiotherapy Load | N | N | 280025907 | CETUXIMAB + RT |
| 280007957 | 280005216 | 1.75 | 73 | Palliative (P) | 2016-02-09 | 2016-09-18 | Doxorubicin 75mg/m2 | null | null | 280025910 | DOXORUBICIN |
| 280007958 | 280005217 | 1.77 | 116 | Palliative (P) | 2016-03-15 | 2016-03-23 | Cisplatin 7 day | N | N | 280025910 | CISPLATIN |
| 280007959 | 280005218 | 1.68 | 81 | Adjuvant (A) | 2016-04-04 | 2016-04-11 | CARBOPLATIN + RT | N | Y | 280025915 | CARBOPLATIN + RT |
| 280007960 | 280005219 | null | 102 | Disease modification (D) | 2017-09-12 | 2017-10-04 | STS Rhabdo RMS 2005 Vin Cyclo | N | Y | 280025916 | RMS 2005 TRIAL |
| 280007961 | 280005220 | null | 44.2 | Palliative (P) | 2013-10-03 | 2013-10-03 | Doxorubicin 75mg/m2 | N | N | 280025917 | DOXORUBICIN |
| 280007962 | 280005222 | 1.6 | 60.9 | Palliative (P) | null | 2017-11-27 | Doxorubicin 75mg/m2 | 02 | N | 280025920 | DOXORUBICIN |
| 280007963 | 280008760 | 0 | 15.4 | Palliative (P) | 2012-09-23 | 2013-04-15 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280025923 | RMS 2005 TRIAL |
| 280007964 | 280005224 | 1.79 | 44.5 | Palliative (P) | null | 2016-06-23 | OST Euramos 1 Closed Trial - A | N | N | 280025924 | DOXORUBICIN |
| 280007965 | 280005225 | null | 92.8 | Palliative (P) | 2017-03-02 | 2017-03-05 | DOXORUBICIN | 02 | N | 280025928 | DOXORUBICIN |
| 280007966 | 280008762 | 1.77 | 85 | Palliative (P) | 2016-06-17 | 2016-08-04 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 280025931 | RMS 2005 TRIAL |
| 280007967 | 280010452 | 1.58 | 112 | Palliative (P) | 2017-01-13 | 2017-01-13 | Paclitaxel 7 day | 02 | N | 280025932 | PACLITAXEL |
| 280007968 | 280005226 | 1.65 | 72.6 | Palliative (P) | null | 2014-09-05 | Cisplatin 7 day | null | null | 280025935 | CISPLATIN |
| 280007969 | 280005226 | 1.6 | null | Palliative (P) | 2017-04-07 | 2017-04-21 | Ifosfamide | N | N | 280025935 | IFOSFAMIDE |
| 280007970 | 280005226 | 1.75 | 73 | Palliative (P) | 2015-05-21 | 2015-05-25 | Paclitaxel 7 day | N | N | 280025935 | PACLITAXEL |
| 280007971 | 280005228 | 1.33 | 91 | Neo-adjuvant (N) | 2014-12-23 | 2015-02-07 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280025945 | RMS 2005 TRIAL |
| 280007972 | 280005229 | 0 | 99 | Palliative (P) | 2016-07-24 | 2016-11-01 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 280025946 | IVA |
| 280007973 | 280008764 | 1.59 | 64 | Adjuvant (A) | 2014-12-15 | 2015-02-03 | CETUXIMAB + RT | 2 | Y | 280025947 | CETUXIMAB + RT |
| 280007974 | 280008764 | 1.63 | 35.5 | Palliative (P) | 2017-08-25 | 2017-08-25 | Doxorubicin 75mg/m2 | N | N | 280025947 | DOXORUBICIN |
| 280007975 | 280005231 | 1.7 | 96 | null | 2014-05-17 | 2014-05-19 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 280025954 | PACLITAXEL |
| 280007976 | 280005233 | 1.6 | 78 | Palliative (P) | 2016-03-17 | 2016-03-21 | CETUXIMAB + RT | N | Y | 280025956 | CETUXIMAB + RT |
| 280007977 | 280005233 | 1.74 | 64.45 | Palliative (P) | 2015-07-20 | 2015-07-21 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280025956 | PACLITAXEL |
| 280007978 | 280005234 | 1.71 | 70.8 | Curative (C) | 2017-10-02 | 2017-10-27 | Cetuximab + Radiotherapy Maint | N | N | 280025964 | CETUXIMAB + RT |
| 280007979 | 280008767 | 1.75 | 86.45 | Adjuvant (A) | 2017-04-28 | 2017-05-01 | CARBOPLATIN + RT | N | N | 280025965 | CARBOPLATIN + RT |
| 280007980 | 280005235 | 1.88 | null | Palliative (P) | 2017-07-06 | 2017-07-23 | Ifosfamide | N | null | 280025968 | IFOSFAMIDE |
| 280007981 | 280005235 | 1.72 | 62.3 | Not known (9) | 2017-06-02 | 2017-06-14 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280025968 | PACLITAXEL |
| 280007982 | 280005236 | 0.99 | 65.3 | Palliative (P) | 2017-11-15 | 2017-11-15 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | 280025972 | IVA |
| 280007983 | 280005238 | 1.9 | 50.7 | Palliative (P) | 2016-01-16 | 2016-02-09 | Cisplatin | 02 | null | 280025973 | CISPLATIN |
| 280007984 | 280005239 | 1.7 | 50.45 | Palliative (P) | 2016-10-29 | 2016-11-13 | Cetuximab + Radiotherapy Maint | N | Y | 280025976 | CETUXIMAB + RT |
| 280007985 | 280008769 | 1.74 | 50.8 | Curative (C) | 2018-01-11 | 2018-02-07 | Ifosfamide PVI 1g/m2 14day | 02 | N | 280025978 | IFOSFAMIDE |
| 280007986 | 280005240 | 1.58 | 68 | Neo-adjuvant (N) | null | 2017-08-28 | DOXORUBICIN | null | N | 280025980 | DOXORUBICIN |
| 280007987 | 280005240 | 1.8 | 68.4 | Curative (C) | 2015-12-01 | 2016-03-06 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | Y | 280025980 | IVA |
| 280007988 | 280008771 | 1.76 | 36.7 | Palliative (P) | 2014-12-16 | 2014-12-30 | Cisplatin 7 day | N | Y | 280025986 | CISPLATIN |
| 280007989 | 280005242 | 1.69 | 86.6 | Palliative (P) | 2013-04-25 | 2013-04-29 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280025987 | PACLITAXEL |
| 280007990 | 280008772 | 1.68 | 19.2 | Palliative (P) | 2016-07-23 | 2016-08-15 | Cisplatin | N | N | 280025990 | CISPLATIN |
| 280007991 | 280008772 | 1.7 | 79 | Palliative (P) | 2017-10-22 | 2017-11-24 | Ifosfamide | 2 | N | 280025990 | IFOSFAMIDE |
| 280007992 | 280011287 | 1.7 | 66.8 | Curative (C) | 2017-06-15 | 2017-08-25 | CARBOPLATIN + RT | null | Y | 280025996 | CARBOPLATIN + RT |
| 280007993 | 280011901 | 1.65 | null | Curative (C) | 2016-05-13 | 2016-06-28 | STS Rhabdomyosarcoma RMS 2005 IVA | N | Y | 280025997 | IVA |
| 280007994 | 280011901 | 1.98 | 93.8 | Curative (C) | 2013-07-18 | 2013-10-03 | Cetuximab + Radiotherapy Maint | 02 | Y | 280025997 | CETUXIMAB + RT |
| 280007995 | 280005243 | 1.55 | 51.8 | Curative (C) | 2014-11-01 | 2014-12-14 | Cisplatin 7 day | 02 | N | 280026003 | CISPLATIN |
| 280007996 | 280005244 | 1.7 | 72.6 | Palliative (P) | 2017-09-28 | 2017-10-05 | PACLITAXEL | 02 | N | 280026005 | PACLITAXEL |
| 280007997 | 280005245 | 1.71 | 79.8 | Palliative (P) | 2017-02-16 | 2017-03-02 | Cetuximab + Radiotherapy Maint | 02 | N | 280026007 | CETUXIMAB + RT |
| 280007998 | 280005245 | 1.72 | 14.7 | Curative (C) | 2016-05-03 | 2016-06-22 | CARBOPLATIN + RT | null | Y | 280026007 | CARBOPLATIN + RT |
| 280007999 | 280005246 | 1.81 | 81 | Palliative (P) | 2017-01-17 | 2017-01-19 | Paclitaxel 7 day | N | N | 280026014 | PACLITAXEL |
| 280008000 | 280005247 | 1.65 | 64.2 | Adjuvant (A) | 2013-03-19 | 2013-09-10 | CARBOPLATIN + RT | N | N | 280026014 | CARBOPLATIN + RT |